Application no. and date | 01909661.9 (espacenet) (Federated) (European Patent Register), 20010119 | Patent/reg. no. and date | DK/EP 1248604, 20061129 | Publication date | 20021016 | Priority no. and date | US 489234, 20000121, US 619262, 20000719 | EP pub. no. and date |
EP 1248604 20021016 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 128367 | Inventor | HUGHES, Thomas, Edward, 76 Fisher Drive
Somerville, NJ 08876, US, HOLMES, David, Grenville, Holeeholzweg 76
CH-4102 Binningen, CH, BALKAN, Börk, 20 Northwood Road
Madison, CT 06443, US, VILLHAUER, Edwin, Bernard, 20 Dorothy Drive
Morristown, NJ 07960, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 31/4025 (2006.01) , A61K 31/44 (2006.01) , A61K 31/505 (2006.01) , A61K 45/06 (2006.01) , A61P 3/10 (2006.01) | Title | Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler | Int. application no. | EP2001000590 | Int. publication no. | WO2001052825 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|